349 related articles for article (PubMed ID: 35239653)
1. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.
Palmos AB; Millischer V; Menon DK; Nicholson TR; Taams LS; Michael B; Sunderland G; Griffiths MJ; ; Hübel C; Breen G
PLoS Genet; 2022 Mar; 18(3):e1010042. PubMed ID: 35239653
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
[TBL] [Abstract][Full Text] [Related]
3. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
Elife; 2021 Aug; 10():. PubMed ID: 34402426
[TBL] [Abstract][Full Text] [Related]
4. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.
Cui Z; Tian Y
J Transl Med; 2021 Jul; 19(1):300. PubMed ID: 34246301
[TBL] [Abstract][Full Text] [Related]
5. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
Qu HQ; Qu J; Glessner J; Hakonarson H
Metabolism; 2022 Apr; 129():155156. PubMed ID: 35101533
[TBL] [Abstract][Full Text] [Related]
7. Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19.
Strausz S; Agafonova E; Tiullinen V; Kiiskinen T; Broberg M; Ruotsalainen SE; Koskela J; Bachour A; Sofer T; Gottlieb DJ; Palotie A; Palotie T; Ripatti S; Ollila HM
Ann Am Thorac Soc; 2024 Jun; 21(6):961-970. PubMed ID: 38330144
[No Abstract] [Full Text] [Related]
8. The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
Butler-Laporte G; Nakanishi T; Mooser V; Renieri A; Amitrano S; Zhou S; Chen Y; Forgetta V; Richards JB
Int J Epidemiol; 2021 Mar; 50(1):75-86. PubMed ID: 33349849
[TBL] [Abstract][Full Text] [Related]
9. Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study.
Li S; Hua X
BMC Med Genomics; 2021 Feb; 14(1):38. PubMed ID: 33536004
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
Leong A; Cole JB; Brenner LN; Meigs JB; Florez JC; Mercader JM
PLoS Med; 2021 Mar; 18(3):e1003553. PubMed ID: 33661905
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
[TBL] [Abstract][Full Text] [Related]
12. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
13. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies.
Luo S; Liang Y; Wong THT; Schooling CM; Au Yeung SL
Int J Epidemiol; 2022 Aug; 51(4):1088-1105. PubMed ID: 35445260
[TBL] [Abstract][Full Text] [Related]
14. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
[TBL] [Abstract][Full Text] [Related]
15. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
Park J; Kim H; Kim SY; Kim Y; Lee JS; Dan K; Seong MW; Han D
Sci Rep; 2020 Dec; 10(1):22418. PubMed ID: 33376242
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
Li GH; Tang CM; Cheung CL
Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
[No Abstract] [Full Text] [Related]
17. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.
Li C; Wu A; Song K; Gao J; Huang E; Bai Y; Liu X
Cells; 2021 Dec; 10(12):. PubMed ID: 34944012
[TBL] [Abstract][Full Text] [Related]
18. Using genetics and proteomics data to identify proteins causally related to COVID-19, healthspan and lifespan: a Mendelian randomization study.
Zhao JV; Yao M; Liu Z
Aging (Albany NY); 2024 Apr; 16(7):6384-6416. PubMed ID: 38575325
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes.
Viode A; Smolen KK; van Zalm P; Stevenson D; Jha M; Parker K; ; Levy O; Steen JA; Steen H
Sci Adv; 2024 May; 10(21):eadl5762. PubMed ID: 38787940
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization.
Lorincz-Comi N; Zhu X
Sci Rep; 2021 Apr; 11(1):7848. PubMed ID: 33846372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]